The Role of Gut Microbial β-Glucuronidase in Estrogen Reactivation and Breast Cancer
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Over the past decade, the gut microbiota has received considerable attention for its interactions with the host. Microbial β-glucuronidase generated by this community has hence aroused concern for its biotransformation activity to a wide range of exogenous (foreign) and endogenous compounds. Lately, the role of gut microbial β-glucuronidase in the pathogenesis of breast cancer has been proposed for its estrogen reactivation activity. This is plausible considering that estrogen glucuronides are the primary products of estrogens’ hepatic phase II metabolism and are subject to β-glucuronidase-catalyzed hydrolysis in the gut via bile excretion. However, research in this field is still at its very preliminary stage. This review outlines the biology of microbial β-glucuronidase in the gastrointestinal tract and elaborates on the clues to the existence of microbial β-glucuronidase–estrogen metabolism–breast cancer axis. The research gaps in this field will be discussed and possible strategies to address these challenges are suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · cited 1×
“Even though the results were not always consistent, the increase in Firmicutes and decrease in Bacteroidetes or increased Firmicutes-to-Bacteroidetes ratio are considered as an important sign of obesity (Sekirov et al., 2010; Daniel et al., 2014; Gilbert et al., 2016; John and Mullin, 2016; Luu et al., 2017).”
ResultMeasurement of gastrointestinal pH profiles in normal ambulant human subjects
Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., & Hardcastle, J. D. (1988) · Gut · doi:10.1136/gut.29.8.1035 · Cited by 1,240
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Plottel, C. S., & Blaser, M. J. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.003 · Cited by 743
Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M., Booijink, C. C. G. M., Troost, F. J., Bork, P., Wels, M., de Vos, W. M., & Kleerebezem, M. (2012) · The ISME Journal · doi:10.1038/ismej.2011.212 · Cited by 722
Flores, R., Shi, J., Fuhrman, B., Xu, X., Veenstra, T. D., Gail, M. H., Gajer, P., Ravel, J., & Goedert, J. J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-253 · Cited by 615
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450 · cited 2×
“As shown in Figure 1, both parent estrogens and related phase I metabolites can be conjugated with glucuronic acid in 2-, 3-, 4-, 16α-, and 17-positions (Figure 2) by the catalyzation of UGT in the liver or GI epithelium (Schiffer et al., 2019).”
BackgroundMicrobial shifts in the aging mouse gut
Langille, M. G., Meehan, C. J., Koenig, J. E., Dhanani, A. S., Rose, R. A., Howlett, S. E., & Beiko, R. G. (2014) · Microbiome · doi:10.1186/s40168-014-0050-9 · Cited by 437 · cited 1×
“Generally, for both humans and murine, the overall gmGUS activity increased with age (Goldin et al., 1978; Mykkänen et al., 1997; Grönlund et al., 1999; Langille et al., 2014; Nowak et al., 2014), but whether this tendency is consistent among microbes is still unclear.”
BackgroundErvin, S. M., Li, H., Lim, L., Roberts, L. R., Liang, X., Mani, S., & Redinbo, M. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010950 · Cited by 397
Goedert, J. J., Jones, G., Hua, X., Xu, X., Yu, G., Flores, R., Falk, R. T., Gail, M. H., Shi, J., Ravel, J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv147 · Cited by 393
Breast cancer in postmenopausal women is associated with an altered gut metagenome
Zhu, J., Liao, M., Yao, Z., Liang, W., Li, Q., Liu, J., Yang, H., Ji, Y., Wei, W., Tan, A., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0515-3 · Cited by 377 · cited 1×
“In recent years, 16S rRNA gene sequencing and metagenome sequencing have been widely applied in microbial-related research (Gopalakrishnan et al., 2018; Zhu et al., 2018).”
BackgroundOestrogen exposure and breast cancer risk
Travis, R. C., & Key, T. J. (2003) · Breast Cancer Research · doi:10.1186/bcr628 · Cited by 346
Fuhrman, B. J., Feigelson, H. S., Flores, R., Gail, M. H., Xu, X., Ravel, J., & Goedert, J. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2222 · Cited by 339
Dabek, M., McCrae, S. I., Stevens, V. J., Duncan, S. H., & Louis, P. (2008) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2008.00520.x · Cited by 332
The gut microbiome and obesity
John, G. K., & Mullin, G. E. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0528-7 · Cited by 304
An atlas of β-glucuronidases in the human intestinal microbiome
Pollet, R. M., D'Agostino, E. H., Walton, W. G., Xu, Y., Little, M. S., Biernat, K. A., Pellock, S. J., Patterson, L. M., Creekmore, B. C., Isenberg, H. N., et al. (2017) · Structure · doi:10.1016/j.str.2017.05.003 · Cited by 289
Sandberg, A. A., & Slaunwhite, W. R. (1957) · Journal of Clinical Investigation · doi:10.1172/jci103524 · Cited by 184
McIntosh, F. M., Maison, N., Holtrop, G., Young, P., Stevens, V. J., Ince, J., Johnstone, A. M., Lobley, G. E., Flint, H. J., & Louis, P. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2012.02711.x · Cited by 132 · cited 2×
“Among them, Bacteroidetes and Firmicutes, which are dominant in the GI tract, are also responsible for the primary source of gmGUS (Table 1; McIntosh et al., 2012; Pollet et al., 2017; Creekmore et al., 2019; Walsh et al., 2020).”
BackgroundDashnyam, P., Mudududdla, R., Hsieh, T.-J., Lin, T.-C., Lin, H.-Y., Chen, P.-Y., Hsu, C.-Y., & Lin, C.-H. (2018) · Scientific Reports · doi:10.1038/s41598-018-34678-z · Cited by 108
Kong, R., Liu, T., Zhu, X., Ahmad, S., Williams, A. L., Phan, A. T., Zhao, H., Scott, J. E., Yeh, L.-A., & Wong, S. T. C. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0395 · Cited by 90 · cited 1×
“In this case, the “bacterial loop,” which is a bacteria-specific structure missing in the orthologous mammalian GUS, has been used as a useful target for developing bacterial GUS-specific inhibitors (Wallace et al., 2010; Kong et al., 2014; Jariwala et al., 2020).”
Method
Cited by
Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism
Hu, S., Ding, Q., Zhang, W., Kang, M., Ma, J., & Zhao, L. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2236749 · Cited by 274
Systematic Review and Meta-Analysis of the Impact of Bariatric Surgery on Future Cancer Risk
Wilson, R. B., Lathigara, D., & Kaushal, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076192 · Cited by 144
Metadata
- Authors
- Sui, Y., Wu, J., & Chen, J.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2021-08-12
- Volume
- 9
- Pages
- 631552-631552
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3193922083
- Cited by
- 162
- References
- 22
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.